Target intelligence / Profile preview

Subtilisin-like serine protease C (CspC) (CspC)

Target
CspC
Molecular classification
Pseudoprotease, Receptor
01

Overview

Subtilisin-like serine protease C (CspC) is the primary molecular receptor responsible for initiating the germination of Clostridioides difficile spores in response to host signals. Although it belongs to the subtilisin-like protease family, CspC is a pseudoprotease that lacks catalytic activity and has evolved to function as a specialized receptor for bile acids, such as taurocholate, within the mammalian gut (Francis et al., 2013, Nature). Upon binding to germinants, CspC triggers a signaling cascade that activates the protease CspB, which subsequently processes the cortex-lytic enzyme SleC to allow for spore outgrowth and the transition to toxin-producing vegetative cells (Bhattacharjee et al., 2016, Scientific Reports). Because C. difficile spores are highly resistant to antibiotics and are the primary cause of disease recurrence, CspC represents a critical therapeutic target for preventing the onset of infection. Current drug development efforts focus on small molecule inhibitors and bile acid analogs that can block CspC to maintain spores in a dormant, non-pathogenic state (Kochan et al., 2017, PLOS Pathogens).

Other names
Bile acid germinant receptorClostridioides difficile spore germination receptorCspC pseudoproteaseCD1022
02

Mechanism of action

Inhibition of the bile acid-induced germination signaling pathway by acting as a competitive or non-competitive antagonist at the CspC receptor site.

03

Biological functions

Spore germinationSignal transductionBile acid sensing
04

Disease associations

InfectionClostridioides difficile infection (CDI)Recurrent Clostridioides difficile infection
05

Safety considerations

Potential off-target interaction with host bile acid receptors such as FXR or TGR5Alteration of the intestinal bile acid poolImpact on the recovery of commensal gut microbiotaRequirement for stable delivery to the anaerobic environment of the colon
06

Interacting drugs

Taurocholate

4 more in the full profile.

07

Biomarkers

Fecal bile acid profileC. difficile spore concentrationPrimary-to-secondary bile acid ratio

Beyond the preview

Go deeper on Subtilisin-like serine protease C (CspC) (CspC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Subtilisin-like serine protease C (CspC) (CspC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call